Regeneron: Driven by Science
For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.
Regeneron Reports Second Quarter 2015 Financial and Operating Results08/04/15
TARRYTOWN, N.Y., Aug. 4, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2015 and provided an update on development programs. Financial Highlights ($ in m...